Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. The TRIPOD Group.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 4297220)

Published in Circulation on January 05, 2015

Authors

Gary S Collins1, Johannes B Reitsma2, Douglas G Altman2, Karel G M Moons2, TRIPOD Group

Author Affiliations

1: From Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, United Kingdom, and Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands. The current affiliation for Drs Collins and Altman is the Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford OX3 7LD, United Kingdom. The current affiliation for Drs Reitsma and Moons is the Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, PO Box 85500, 3508 GA Utrecht, the Netherlands. gary.collins@csm.ox.ac.uk.
2: From Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, United Kingdom, and Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands. The current affiliation for Drs Collins and Altman is the Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford OX3 7LD, United Kingdom. The current affiliation for Drs Reitsma and Moons is the Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, PO Box 85500, 3508 GA Utrecht, the Netherlands.

Articles cited by this

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med (2009) 35.37

Cardiovascular disease risk profiles. Am Heart J (1991) 21.65

European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg (1999) 17.03

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ (2007) 14.52

2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24

Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol (2001) 10.16

Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst (2005) 9.38

Assessing the generalizability of prognostic information. Ann Intern Med (1999) 8.04

Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA (1997) 7.71

Guidance for developers of health research reporting guidelines. PLoS Med (2010) 7.43

A prognostic index in primary breast cancer. Br J Cancer (1982) 7.35

Prognosis and prognostic research: validating a prognostic model. BMJ (2009) 6.54

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology (2007) 5.77

Translating clinical research into clinical practice: impact of using prediction rules to make decisions. Ann Intern Med (2006) 5.17

A study to develop clinical decision rules for the use of radiography in acute ankle injuries. Ann Emerg Med (1992) 4.87

A simplified acute physiology score for ICU patients. Crit Care Med (1984) 4.55

Prognosis and prognostic research: what, why, and how? BMJ (2009) 4.46

Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ (2009) 4.38

Prognosis and prognostic research: Developing a prognostic model. BMJ (2009) 4.38

Comparisons of established risk prediction models for cardiovascular disease: systematic review. BMJ (2012) 4.16

Ten steps towards improving prognosis research. BMJ (2009) 3.44

Prognosis Research Strategy (PROGRESS) 3: prognostic model research. PLoS Med (2013) 3.13

Reproducible research: moving toward research the public can really trust. Ann Intern Med (2007) 3.10

Risk prediction models: II. External validation, model updating, and impact assessment. Heart (2012) 3.05

Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart (2012) 2.76

Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Radiology (2003) 2.73

Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med (2015) 2.71

Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. BMC Med (2011) 2.44

STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med (2009) 2.39

A systematic review finds prediction models for chronic kidney disease were poorly reported and often developed using inappropriate methods. J Clin Epidemiol (2012) 2.33

Internal and external validation of predictive models: a simulation study of bias and precision in small samples. J Clin Epidemiol (2003) 2.28

Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis. BMC Med Res Methodol (2006) 2.27

Reporting and methods in clinical prediction research: a systematic review. PLoS Med (2012) 2.26

Prognosis Research Strategy (PROGRESS) 2: prognostic factor research. PLoS Med (2013) 2.23

Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration. BMC Med (2012) 1.85

Reporting methods in studies developing prognostic models in cancer: a review. BMC Med (2010) 1.68

External validation of multivariable prediction models: a systematic review of methodological conduct and reporting. BMC Med Res Methodol (2014) 1.57

Assessing the incremental value of diagnostic and prognostic markers: a review and illustration. Eur J Clin Invest (2011) 1.46

Prediction models for prolonged intensive care unit stay after cardiac surgery: systematic review and validation study. Circulation (2010) 1.37

Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist. PLoS Med (2014) 1.35

Registration of observational studies: is it time? CMAJ (2010) 1.33

Estimating treatment effects for individual patients based on the results of randomised clinical trials. BMJ (2011) 1.32

Conflicts at the heart of the FRAX tool. CMAJ (2013) 1.19

Use of reclassification for assessment of improved prediction: an empirical evaluation. Int J Epidemiol (2011) 1.11

Fracture risk assessment: state of the art, methodologically unsound, or poorly reported? Curr Osteoporos Rep (2012) 1.07

Canadian C-Spine Rule study for alert and stable trauma patients: I. Background and rationale. CJEM (2002) 1.02

Diagnostic prediction rules: principles, requirements and pitfalls. Prim Care (1995) 1.01

Framework for the impact analysis and implementation of Clinical Prediction Rules (CPRs). BMC Med Inform Decis Mak (2011) 0.97

Risk assessment of fragility fractures: summary of NICE guidance. BMJ (2012) 0.95

Comparing risk prediction models. BMJ (2012) 0.94

Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Eur J Clin Invest (2011) 0.91

Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Eur J Clin Invest (2011) 0.85

Canadian C-Spine Rule study for alert and stable trauma patients: II. Study objectives and methodology. CJEM (2002) 0.85

Developing and evaluating prediction models in rehabilitation populations. Arch Phys Med Rehabil (2012) 0.85